GlaxoSmithKline Pharmaceuticals Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 8,433.5 million compared to INR 7,916.2 million a year ago. Net income was INR 143.3 million compared to INR 1,380.7 million a year ago. Basic earnings per share from continuing operations was INR 0.85 compared to INR 8.15 a year ago.